Obstacles Impeding The Development of Nanocarriers for Anticancer Drugs

Click to increase image sizeClick to decrease image size

Author contributions

L Liu: substantial contribution to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work; and drafting the work or revising it critically for important intellectual content; H Dou: final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Financial & competing interests disclosure

The authors wish to gratefully acknowledge financial support from the National Natural Science Foundation of China (21871180), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (SHDP201802), the ‘Shuguang Program’ supported by the Shanghai Municipal Education Commission (17SG12), the Science and Technology Commission of Shanghai Municipality (18520710300 and 17ZR1404100) and Biomedical Interdisciplinary Research Foundation of SJTU (YG2019QNB34). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

The authors wish to gratefully acknowledge financial support from the National Natural Science Foundation of China (21871180), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (SHDP201802), the ‘Shuguang Program’ supported by the Shanghai Municipal Education Commission (17SG12), the Science and Technology Commission of Shanghai Municipality (18520710300 and 17ZR1404100) and Biomedical Interdisciplinary Research Foundation of SJTU (YG2019QNB34). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.